Indegene Ltd
NSE: INDGN | BSE: 544172
₹512.55
₹3.30
(0.65%)
As on 22-May-2026 13:29IST
Market cap
₹12,303 Cr
Revenue (TTM)
₹3,511 Cr
P/E Ratio
30.7
P/B Ratio
3.9
Div. Yield
0.4 %
Quality Score
10/10
Growth Score
7/10
Valuation Score
6/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹401 Cr
-
ROE
20.5 %
-
ROCE
25.2 %
-
Industry P/E
--
-
EV/EBITDA
17.3
-
Debt to Equity
0
-
Book Value
₹130.3
-
EPS
₹17.3
-
Face value
2
-
Shares outstanding
240,901,354
10 Years Aggregate
CFO
₹1,715.75 Cr
EBITDA
₹2,289.32 Cr
Net Profit
₹1,499.81 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indegene
| -1.5 | 5.2 | 5.7 | -14.6 | -- | -- | -- |
|
BSE Healthcare
| 9.5 | 9.4 | 10.3 | 11.6 | 27.8 | 14.2 | 12.0 |
|
Company
|
2025
|
|---|---|
|
Indegene
| -14.2 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indegene
|
512.6 | 12,302.8 | 3,510.5 | 401.1 | 14.0 | 13.9 | 30.7 | 3.9 |
| 197.9 | 3,089.4 | 2,931.9 | 97.5 | 7.7 | 1.5 | 31.7 | 0.5 | |
| 152.6 | 679.0 | 410.8 | 38.0 | 7.2 | 11.9 | 17.7 | 1.6 | |
| 22.5 | 679.5 | 1,449.5 | 55.0 | 6.8 | 11 | 13.1 | 1.4 | |
| 1,119.1 | 23,798.3 | 2,192.5 | 348.9 | 21.2 | 14.9 | 68.2 | 9.6 | |
| 4,759.6 | 10,945.8 | 935.0 | 257.9 | 34.3 | 78.9 | 42.4 | 24.2 | |
| 29.0 | 434.5 | 54.2 | 10.9 | -4.1 | 13.9 | 40 | 14.0 |
Shareholding Pattern
View DetailsNews & Analysis
All News
5 min read•By Samridh Rela
About Indegene
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions,... Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India. Read more
-
Incorporated
1998
-
Chairman
Manish Gupta
-
Managing Director
--
-
Headquarters
Bengaluru, Karnataka
-
Website
Looking for more details about Indegene Ltd’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Of Outcome Of Board Meeting
29-Apr-2026Intimation Of Opening Of Trading Window
29-Apr-2026No News & Announcements are available.
FAQs for Indegene
What is the current share price of Indegene Ltd Today?
The share price of Indegene Ltd is ₹512.55 (NSE) and ₹512.05 (BSE) as of 22-May-2026 13:29 IST. Indegene Ltd has given a return of -14.63% in the last 1 years.
What is the current PB & PE ratio of Indegene Ltd?
The P/E ratio of Indegene Ltd is 30.67 times as on 22-May-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
34.05
|
5.37
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Indegene Ltd?
The 52-week high and low of Indegene Ltd are Rs 632.90 and Rs 414.00 as of 22-May-2026.
What is the market cap of Indegene Ltd?
Indegene Ltd has a market capitalisation of ₹ 12,303 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Indegene Ltd?
Before investing in Indegene Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.